BlackRock Health Sciences Trust II (BMEZ) Research

BlackRock Health Sciences Term Trust is a managed, closed-end investment fund designed to achieve overall returns and generate income. It aims to accomplish these goals through a blend of immediate earnings, short-term profits, and substantial capital growth over the long term. The trust was established on August 14, 2019, with its main office situated in Wilmington, Delaware.

Market snapshot

Symbol
BMEZ
Price
$14.55
Day change
0.00%
Market cap
$514.4M
P/E ratio
6.68x
52-week range
13.67-15.8
Sector
Financial Services
Industry
Asset Management

Peer companies

  • BlackRock Capital Allocation Trust (BCAT)
  • BlackRock Enhanced Equity Dividend Trust (BDJ)
  • BlackRock Science and Technology Trust (BST)
  • Blackrock Municipal 2030 Target Term Trust (BTT)
  • BlackRock ESG Capital Allocation Trust (ECAT)
  • Franklin Growth Allocation Fund Class R (FGTRX)
  • Fidelity Advisor Dividend Growth Z (FZADX)
  • Schwab Target 2030 Index Fund Institutional Shares (SWYEX)

Recent insider activity

  • Liu Xiang — M-Exempt (523.331 shares) on 2026-01-30
  • Liu Xiang — A-Award (1026.693 shares) on 2026-01-30
  • Liu Xiang — M-Exempt (777.9221 shares) on 2026-01-30
  • Liu Xiang — M-Exempt (254.5911 shares) on 2026-01-30
  • Liu Xiang — D-Return (777.9221 shares) on 2026-01-30

Open BlackRock Health Sciences Trust II (BMEZ) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.